aplastic anemia | Page 4 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia

Author(s): 
Mary Eapen, Mei-Jie Zhang, Xiao-Ying Tang, Stephanie J Lee, Ming-Wei Fei, Hai-Lin Wang, Kyle M Hebert, Mukta Arora, Saurabh Chhabra, Steven M Devine, Mehdi Hamadani, Anita D'Souza, Marcelo C Pasquini, Rachel Phelan, J Douglas R
Primary Author: 
Eapen M
Journal Title: 
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation
Original Publication Date: 
May 2020

With the COVID-19 pandemic and the ensuing barriers to the collection and transport of donor cells, it is often necessary to collect and cryopreserve grafts before initiation of transplantation conditioning. The effect on transplantation outcomes in nonmalignant disease is unknown.

Bone Marrow Diseases: 

Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Author(s): 
Lova Sun, Daria V Babushok
Primary Author: 
Sun, Lova
Journal Title: 
Blood
Original Publication Date: 
May 2020

Acquired

Ilene Weitz, MD

Weitz, Ilene
Professor of Clinical Medicine
University of Southern California

Dr. Ilene C. Weitz is an Associate Professor of Clinical Medicine at the Keck School of Medicine at the University of Southern California (USC). Her practice sites include, LAC+USC Medical Center, Keck Hospital of USC and USC Norris Cancer Hospital. Dr. Weitz is board certified in Internal Medicine and Hematology.

Nikolai Podoltsev, MD, PhD

Podoltsev, Nikolai
Associate Director of the Hematology/Oncology Fellowship Program
Smilow Cancer Hospital at Yale

Dr. Podoltsev practice is focused on myeloid neoplasms including acute myelogenous leukemias (AML), myelodisplastic syndromes (MDS), myeloproliferative neoplasms (MPNs) like polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), chronic myelogenous leukemia (CML) among others. He is providing care for patients with

Thomas Prebet, MD, PhD

Prebet, Thomas
Medical Director of Hematology and Cell Therapy
Smilow Cancer Hospital at Yale

After completing his doctorate in medical hematology and oncology in Lyon, France, Dr. Prebet joined Institut Paoli-Calmettes in Marseille, France and completed a fellowship in Johns Hopkins University (Baltimore, MA, USA) as a Fullbright alumni. Dr. Prebet is currently the director of the inpatient hematology unit and the medical director of the hematology division of Yale

2020 National Virtual Patient & Family Conference

AAMDSIF hosted the 2020 National Patient & Family Conference ONLINE over three days, July 17 - 19, 2020. The Conference featured three days of educational workshops, panels and speakers for patients, families and caregivers with

Event Date: 
Fri, 07/17/2020 to Sun, 07/19/2020